264W94 is a potent ileal bile acid transporter (IBAT) inhibitor and a novel cholesterol-lowering agent; it exhibits CYP7A1 induction activity and anti-hyperlipidemic effects; it dose-dependently attenuates diet-induced increases in serum LDL+VLDL cholesterol and prevents the decrease in HDL cholesterol; it increases fecal excretion of bile acids; it reduces plasma glucose levels in male ZDF rats; it prevents the decline of insulin in a dose-dependent manner without increasing proinsulin levels.